Pure cultures ofhuman breast epithelial cells and of fibroblastic cells in early passage provided the opportunity to ask whether either cell type had the capability for metabolizing chemical carcinogens and, ifso, was the fate ofthe metabolic products compatible with chemical carcinogens being a factor in the initiation of breast cancer in women. For this purpose, cells were exposed to benzo [a]pyrene (BaP), and (i) the influence on growth potential and (ii) the extent, type, and persistence of adducts between the metabolites of BaP and DNA were measured. Compared with fibroblasts, inhibition of growth by epithelial cells was 50-100 times more sensitive to BaP. Because of this differential sensitivity, epithelial cells were exposed to 0.4 FM BaP and fibroblasts were exposed to 4.0 FM BaP in the studies of DNA adduct formation. Separation by high-pressure liquid chromatography of adducts between (±)-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a] The ubiquitous presence of benzo[a]pyrene (BaP) as an environmental pollutant from the incomplete combustion of fossil fuels (1-3) and its potency as a mutagen (2) and carcinogen (3-9) after activation are well documented. The (±)-7,8-dihydroxy-9, 10-epoxy-7,8,9, 10-tetrahydrobenzo[a]pyrenes (BaP-diol epoxides) are the set of metabolites most strongly linked to carcinogenic transformation (3, 4). Of the four isomeric forms of BaP diol epoxide, the 7/3,8a-dihydroxy-9a, lOa-epoxy-7,8,-9, 10-tetrahydrobenzo[a]pyrene (anti BaP diol epoxide), particularly the (7R) or (+) enantiomer, is the most carcinogenic in rodent model systems (7,8), and formation of adducts between this metabolite and deoxyguanosine of DNA predominates in cells susceptible to carcinogenic transformation (9,10 -7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene; anti BaP diol epoxide, (+)-7,B,8a-dihydroxy-9a, 8,9,benzo[a]pyrene; syn BaP diol epoxide, (+)-7f3,8a-dihydroxy-9,8,10f-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene; HPLC, high-pressure liquid chromatography; bp, base pair(s).